Diabetes News

Medindia's Press Release’ section provides the latest press release on Diabetes from across the world for the global audience. This page links to 1367 Diabetes press releases.

Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study

SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., Dec. 15 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) today announced positive results from a ...


183 New Medicines in Development for Diabetes

WASHINGTON, Dec. 11 Nabe News in Brooklyn, New York recently reported that 183 new medicines are in development to fight diabetes. The report details a record number of drugs for this chronic disease currently in human clinical trials ...

Bears Quarterback Jay Cutler and Eli Lilly and Company Will Send 44 Kids to American Diabetes Association Camps Through the Touchdowns for Diabetes Campaign

CHICAGO, Dec. 11 Chicago Bears' quarterback Jay Cutler and Eli Lilly and Company (Lilly) have already helped send 44 children to American Diabetes Association diabetes camps next summer - with four games left in the NFL season. ...

ARKRAY, Inc. Receives FDA 510k Clearance on the Assure(R) Platinum Auto-Code Blood Glucose Monitoring System

EDINA, Minn., Dec. 10 ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today received FDA clearance on the new Assure Platinum Blood Glucose Monitoring System. The Assure Platinum Blood Glucose ...

Mobile Phone Technology May Address Unmet Needs of Parents of Children With Diabetes, Sending Blood Sugar Readings Via Text, to Help Manage Child's Illness

According to new study conducted by the Center for Connected Health, parents most concerned about access to their child's healthcare provider BOSTON, Dec. 8 /PRNewswire-USNewswire/ -- In a recent study conducted by the Center for ...

Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year

New Solution Streamlines How Patients Access Information CHICAGO , Dec. 8 -- By leveraging Ifbyphone's Virtual Call Center software and bringing its outsourced call center in-house, DiabetesAmerica has saved over 50% while also ...

Lilly Announces the First 300-unit Vial of Insulin

INDIANAPOLIS, Dec. 7 Eli Lilly and Company (NYSE: LLY) today announced the availability of a smaller insulin vial, the first in the United States containing 3 mL (300 units) of insulin, for people with diabetes being treated in a ...

Diabetes News »

Prediabetes: A Ticking Time Bomb for Early Heart and Kidney Disease

Prediabetes: A Ticking Time Bomb for Early Heart and Kidney Disease

Prediabetes raises the risk of dying before age 75, especially from heart disease , kidney disease, and acute diabetic complications. Participants with the stricter definition of prediabetes had 2.6 times the risk of dying from acute diabetic ...

MiniMed Extended Infusion Set Could Improve Diabetes Care Sustainability

MiniMed Extended Infusion Set Could Improve Diabetes Care Sustainability

Medical waste from diabetes care, especially from the infusion sets and reservoirs used with insulin pumps, significantly impacts sustainability due to their reliance on single-use plastics ( ). Medtronic's Innovation in Extended ...

Hidden Risks of Early-Onset Diabetes

Hidden Risks of Early-Onset Diabetes

Concerning link between diabetes diagnosed in youth and an increased risk of dementia and related neurodegenerative diseases has been highlighted by a new study by researchers in the Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center at ...

High Prevalence of Eating Disorder Symptoms in Insulin-Dependent Diabetics

High Prevalence of Eating Disorder Symptoms in Insulin-Dependent Diabetics

A recent meta-analysis conducted at the University of Eastern Finland reveals that 25% of patients aged 16 and above with insulin -dependent diabetes show signs of eating disorder symptoms. Alongside common symptoms like binge eating and food ...

Potential Targeted Therapy for Type I Diabetes: Monoclonal Antibodies

Potential Targeted Therapy for Type I Diabetes: Monoclonal Antibodies

Type 1 diabetes, known as T1D, is characterized by an autoimmune response where harmful lymphocytes attack autoantigens found in the pancreatic islets, resulting in the loss of insulin-producing beta cells in the pancreas. The ...

More Diabetes News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.